替罗非班对冠心病PCI术后肌钙蛋白I水平的影响(3)
| 第1页 |
参见附件。
[10] Yang YJ， Zhao JL， You SJ， et al. Different effect of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a miniswine model of acute myocardial infarction and reperfusion [J].Heart， 2006， 92： 1131 - 1137.
[11] Dimitrijevic O， Stojcevski BD， Ignjatovic S， et al. Serial measurements of C-reactive protein after acute myocardial infarction in predicting one-year outcome[J]. Int Heart J， 2006，47： 833 - 842.
[12] Gurbel PA， Bliden KP， Tantry US. Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting： results from the CLEAR PLATELETS 1b study[J]. J Am Coll Cardiol， 2006， 48： 2186 -2191.
[13] Ortolani P， Marzocchi A， Marrozzini C， et al. Long-term effectiveness of early administration of glycoprotein Ⅱb/Ⅲa agents to real-world patients undergoing primary percutaneous interventions：results of a registry study in an ST-elevation myocardial infarction network[J]. Eur Heart J， 2009， 30： 33 - 43.
[14] Alexander D， Mann N， Ou FS， et al. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative)[J]. Am J Cardiol， 2008， 102： 1335 - 1340.
作者单位：福建省立医院心内科；福建医科大学省立临床医学院
您现在查看是摘要介绍页，详见PDF附件。